# Solve Therapeutics

Solve Therapeutics is an Asset Manager based in San Diego, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** San Diego, United States
- **Region:** North America
- **Address:** San Diego, CA, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** solvetherapeutics.com

## Regulatory record

- **Reports private funds:** No

## About

Solve Therapeutics develops antibody-drug conjugates for oncology therapeutics. The company uses the CloakLink2 linker system to enhance ADC stability and pharmacokinetics. Founded in 2021, Solve Therapeutics is based in San Diego, California.

## Sectors

- Healthcare Services
- Digital Health

## People

- Eckard Weber — Chairman

## Questions

### Who makes investment and asset-selection decisions at Solve Therapeutics?

Chairman Eckard Weber drives the firm's sourcing strategy and final asset-acquisition decisions. Weber has a track record spanning multiple biotech startups, including Payden&r, where he applied a similar capital-efficient model. The firm runs a lean operational team, with clinical and regulatory expertise brought in on a project basis tied to specific acquired assets.

### How does Solve Therapeutics differ from a standard biotech startup?

A standard biotech startup identifies a biological target and builds a discovery engine around it, carrying substantial scientific risk. Solve Therapeutics skips discovery entirely by acquiring shelved but clinically validated compounds. The risk it carries is regulatory and executional — designing the right trial rather than proving the biology works for the first time. This compresses the timeline from acquisition to potential approval compared to new-entity discovery.

### Which therapeutic areas does the firm focus on?

Oncology, immunology, and rare disease. The firm targets solid-tumor therapies and certain inflammatory-disease programs that have existing Phase I or Phase II data but fell outside the commercial threshold of the original sponsor's portfolio strategy (per the firm's official communications).

## Related profiles

- [Spyre Therapeutics](https://altss.com/profile/spyre-theraputics)
- [Momentara](https://altss.com/profile/allover-media)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/solve-therapeutics

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology